Novacyt
CE-IVD molecular diagnostics for infectious disease and oncology
Novacyt (through its Primerdesign and Lab21 divisions) develops and manufactures CE-IVD real-time PCR kits, point-of-care tests, and molecular diagnostic instruments. Their genesig assay line covers respiratory pathogens, tropical diseases, STIs, and oncology markers. For Caribbean molecular laboratories, Novacyt provides validated, regulatory-compliant assays on open PCR platforms.
3
Products
2
Product Families
4
Sectors Served
Product Portfolio
genesig Molecular Assays
CE-IVD real-time PCR kits for infectious disease and oncology diagnostics.
genesig Respiratory Assays
Real-time PCR kits for Influenza A/B, RSV, SARS-CoV-2, and other respiratory pathogens. Lyophilized format with room-temperature shipping. CE-IVD marked.
- Lyophilized format
- Room temperature shipping
- CE-IVD marked
- Open platform compatible
genesig Tropical Disease Assays
Individual real-time PCR assays for dengue, Zika, chikungunya, malaria, and other tropical pathogens. Caribbean-relevant pathogen menu.
- Dengue/Zika/Chik targets
- Individual assay format
- Tropical pathogen focus
- CE-IVD marked
Rapid & POCT
Point-of-care rapid tests for infectious disease screening.
Lab21 Rapid Tests
Lateral flow rapid tests for HIV, hepatitis, dengue, syphilis, and respiratory pathogens. CE-marked for point-of-care and laboratory screening.
- Multiple disease targets
- CE marked
- Lateral flow format
- POCT suitable
Applications
- Molecular infectious disease testing
- Tropical disease surveillance
- Respiratory pathogen panels
- Rapid screening
Sectors Served
Interested in Novacyt?
Contact us for pricing, product availability, and technical support for Novacyt products in your territory.